HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vascular grafts.

AbstractAutogenous vein is the conduit of choice in the surgical creation of bypasses of small-to-medium-caliber vessels in patients with peripheral occlusive arterial disease and will remain so for the near future. The success rate of bypasses using conduits of diameters greater than 6 mm has been excellent, whereas the majority of bypasses using smaller conduits fail within 5 years. In addition, due to a steep increase in rates of diabetes and decreasing cardiovascular mortality rates, increasing challenges are presented by this population. These facts have motivated much of the research in the cardiovascular arena over the past four decades, with improved techniques and new materials. Strategies to improve outcomes include the use of alternative materials including autologous, nonautologous and prosthetic grafts, utilizing different methods for their harvesting and preservation; tissue engineering, using either polymer- or biological-based scaffolds for cell seeding; endovascular methodologies; and gene therapy. This report presents an overview of the several options currently available in the management of patients with peripheral arterial occlusive disease, as well as the ongoing research directed towards the creation of an artificial engineered vessel, discussing experimental work in which endothelial cells have been seeded on different scaffolds and finally the potential application of gene therapy in the field of vascular reconstruction.
AuthorsLuis Leon, Howard P Greisler (Affiliation: Department of Surgery, Hines VA Hospital, IL 60141, USA. lleon at lumc.edu)
JournalExpert review of cardiovascular therapy (Expert Rev Cardiovasc Ther) Vol. 1 Issue 4 Pg. 581-94 (Nov 2003) ISSN: 1477-9072 [Print] England
PMID15030257 (Publication Type: Journal Article, Review)
Chemical References
  • Biocompatible Materials
Topics
  • Arterial Occlusive Diseases (genetics, surgery)
  • Biocompatible Materials (therapeutic use)
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation
  • Gene Therapy (methods)
  • Humans
  • Peripheral Vascular Diseases (genetics, surgery)
  • Tissue Engineering (methods)
  • Transplantation, Autologous (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD